Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Max-IR Labs is a biotechnology and medical device company specializing in mid-infrared (MIR) spectroscopy for real-time liquid analysis. The company develops high-sensitivity sensors designed for in-situ monitoring of bioprocesses and rapid medical diagnostics, such as sepsis detection. Their core technology leverages proprietary infrared waveguides to provide lab-quality chemical analysis in a compact, field-deployable format. Max-IR Labs aims to improve efficiency in pharmaceutical manufacturing and clinical outcomes through continuous, reagent-free monitoring. The company's solutions are particularly focused on the real-time detection of metabolites and proteins in complex biological fluids.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Max-IR Labs.